No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
DLB240517P80000
- 0.20
- +0.15+300.00%
15min DelayClose May 8 16:00 ET
0.20High0.20Low
0.20Open0.05Pre Close1 Volume3 Open Interest80.00Strike Price20.00Turnover20.81%IV-3.42%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier8DDays to Expiry0.20Time Value100Contract SizeAmericanOptions Type-0.1447Delta0.0859Gamma413.15Leverage Ratio-0.0332Theta-0.0026Rho-59.77Eff Leverage0.0290Vega
Intraday
- 5D
- 1D
News
Barrington Reaffirms Their Hold Rating on Dolby Laboratories (DLB)
Earnings Call Summary | Dolby Laboratories(DLB.US) Q2 2024 Earnings Conference
The following is a summary of the Dolby Laboratories, Inc. (DLB) Q2 2024 Earnings Call Transcript:Financial Performance:Dolby posted a Q2 revenue of $365 million, marking a 3% decrease compared to the
Dolby Laboratories Is Maintained at Buy by Rosenblatt
Dolby Laboratories Is Maintained at Buy by Rosenblatt
Express News | Rosenblatt Maintains Buy on Dolby Laboratories, Maintains $98 Price Target
Q2 2024 Dolby Laboratories Inc Earnings Call
Dolby Laboratories Inc (DLB) Q2 2024 Earnings Call Transcript Highlights: Navigating Market ...
Comments
Insiders selling shares, particularly below current price, may be a negative signal. The absence of insider buying and significant selling suggest not all insiders see the shares as a bargain. Despite Dolby Laboratories' profitability and growth, insider transactions warrant careful consideration before investing.
Dolby Laboratories Insider Lowered Holding By 100% During Last Year 1
Dolby Laboratories' high P/E ratio suggests investors expect it to keep outperforming the market. The prospect of future growth appears to eclipse the risk of earnings decline, making a significant share price drop unlikely soon.
With Dolby Laboratories' current share price reflecting its optimistic future growth, a potential buying opportunity might present for investors during price drops, especially considering the strength of its balance sheet.
Several insiders selling a high volume of shares could lead to worries among shareholders. However, holding 0.5% of Dolby Laboratories shares implies substantial alliance of insiders with the company. No insider purchases over the last year might suggest a negative signal.
Despite unusual items impacting Dolby Laboratories' earnings, an improvement is predicted. Analysts forecast robust future profitability, indicating Dolby's stronger potential earnings.
Read more